Search
Cixutumumab
go.drugbank.com/drugs/DB12250InvestigationalCixutumumab is a highly specific recombinant human monoclonal antibody with high affinity for the insulin-like growth factor-I receptor (IGF-IR). IGF-IR is overexpressed in a variety of tumour types.
Categories: Receptor, IGF Type 1Methylchloroisothiazolinone
go.drugbank.com/drugs/DB14197ApprovedThe American Contact Dermatitis Society named Methylchloroisothiazolinone the Contact Allergen of the Year for 2013.
T-cell surface glycoprotein CD3
go.drugbank.com/bio_entities/BE0010202TargetHumansIn addition to its role as a TCR coreceptor, it serves as a receptor for ITPRIPL1 (PubMed:38614099). … Indeed, constitutive TCR cycling is dependent on the di-leucine-based (diL) receptor-sorting motif present in CD3G
Synonyms: T-cell receptor T3 delta chain, T-cell receptor T3 zeta chainStrontium chloride Sr-89
go.drugbank.com/drugs/DB09498ApprovedStrontium chloride (Sr-89), initially FDA-approved in 1993, is used as a paliative therapeutic option to help relieve the pain from bone metastases. Strontium chloride is mainly used in cases of metastatic castrate-resistant prostate can...
Pradefovir mesylate
go.drugbank.com/drugs/DB05478InvestigationalPradefovir is undergoing phase II development for the treatment of chronic hepatitis B.
Mirdametinib
go.drugbank.com/drugs/DB07101ApprovedInvestigationalOn February 11, 2025, mirdametinib was approved by the FDA for the treatment of neurofibromatosis type 1 (NF1).
XL844
go.drugbank.com/drugs/DB05149InvestigationalXL844 is investigated for the use and treatment solid tumors. XL844 is a solid.
Lubiprostone
go.drugbank.com/drugs/DB01046ApprovedInvestigationalLubiprostone is a medication used in the management of idiopathic chronic constipation. A prostaglandin E1 derivative, lubiprostone is a bicyclic fatty acid that activates ClC-2 chloride channels located on the apical side of the gastroi...
Categories: Drugs for ConstipationPatent Blue
go.drugbank.com/drugs/DB13967ApprovedInvestigational[L1113] The isomer isosulphan is used in the United States for the same indications than patent blue.[A32574]
Dicoumarol
go.drugbank.com/drugs/DB00266ApprovedDicoumarol is an oral anticoagulant agent that works by interfering with the metabolism of vitamin K. In addition to its clinical use, it is also used in biochemical experiments as an inhibitor of reductases.